Ignite Creation Date:
2024-05-06 @ 3:08 PM
Last Modification Date:
2024-10-26 @ 1:43 PM
Study NCT ID:
NCT04537234
Status:
COMPLETED
Last Update Posted:
2022-04-07
First Post:
2020-08-26
Brief Title:
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine QIV-HD Compared to a Standard-Dose Quadrivalent Influenza Vaccine QIV-SD in Taiwanese Adults 65 Years of Age and Older
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-26
First Submit QC Date:
September 2 2020
Study First Post Date:
2020-09-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-04-07
Last Update Post Date Type:
ACTUAL